24 May 2013
Keywords: 2nd, deal, merck, nanosystems, usa-based, signed, second
Article | 04 July 1997
USA-based NanoSystems has signed a second development and licensingagreement with drug major Merck & Co to collaborate on the evaluation of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 July 1997
3 July 1997
23 May 2013
© 2013 thepharmaletter.com